The Trump administration Friday “ceased” implementation for 2025 of a disputed Biden administration program designed to remediate poor-performing hospices until it can be evaluated further.
Authorized by Congress, the Centers for Medicare & Medicaid Services’ Hospice Special Focus Program, which launched in December 2024, was designed to monitor poor-performing hospices based on a number of quality measures.
Hospice providers selected for the program faced enhanced oversight to facilitate improvement, like inspections every six months instead of every three years. Program enforcement actions can include fines, suspended reimbursements, and termination from the Medicare program.
The agency decision to pause the program was ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.